Tadeonal

Details

Top
Internal ID 3b4c9851-1bbf-41f6-8324-117cf346f005
Taxonomy Organic oxygen compounds > Organic oxides
IUPAC Name (1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalene-1,2-dicarbaldehyde
SMILES (Canonical) CC1(CCCC2(C1CC=C(C2C=O)C=O)C)C
SMILES (Isomeric) C[C@]12CCCC([C@@H]1CC=C([C@@H]2C=O)C=O)(C)C
InChI InChI=1S/C15H22O2/c1-14(2)7-4-8-15(3)12(10-17)11(9-16)5-6-13(14)15/h5,9-10,12-13H,4,6-8H2,1-3H3/t12-,13-,15+/m0/s1
InChI Key AZJUJOFIHHNCSV-KCQAQPDRSA-N
Popularity 94 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O2
Molecular Weight 234.33 g/mol
Exact Mass 234.161979940 g/mol
Topological Polar Surface Area (TPSA) 34.10 Ų
XlogP 3.20
Atomic LogP (AlogP) 3.16
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 2

Synonyms

Top
Tadeonal
Poligodial
Drim-7-ene-11,12-dial
(-)-Tadeonal
Tadeodal
(1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalene-1,2-dicarbaldehyde
UNII-5FAF7T66M7
UNII-A00RAV0W57
(1r,4as,8as)-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalene-1,2-dicarbaldehyde
5FAF7T66M7
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Tadeonal

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9968 99.68%
Caco-2 + 0.8303 83.03%
Blood Brain Barrier + 0.9250 92.50%
Human oral bioavailability + 0.6571 65.71%
Subcellular localzation Mitochondria 0.5082 50.82%
OATP2B1 inhibitior - 0.8546 85.46%
OATP1B1 inhibitior + 0.8226 82.26%
OATP1B3 inhibitior + 0.8314 83.14%
MATE1 inhibitior - 0.7600 76.00%
OCT2 inhibitior - 0.5750 57.50%
BSEP inhibitior - 0.8879 88.79%
P-glycoprotein inhibitior - 0.9299 92.99%
P-glycoprotein substrate - 0.9206 92.06%
CYP3A4 substrate + 0.5243 52.43%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8679 86.79%
CYP3A4 inhibition - 0.8484 84.84%
CYP2C9 inhibition - 0.7153 71.53%
CYP2C19 inhibition + 0.5522 55.22%
CYP2D6 inhibition - 0.9412 94.12%
CYP1A2 inhibition - 0.8494 84.94%
CYP2C8 inhibition - 0.8286 82.86%
CYP inhibitory promiscuity - 0.6175 61.75%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7900 79.00%
Carcinogenicity (trinary) Non-required 0.5761 57.61%
Eye corrosion - 0.9775 97.75%
Eye irritation - 0.9279 92.79%
Skin irritation - 0.6040 60.40%
Skin corrosion - 0.9700 97.00%
Ames mutagenesis - 0.9200 92.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6170 61.70%
Micronuclear - 0.9300 93.00%
Hepatotoxicity - 0.5584 55.84%
skin sensitisation + 0.8445 84.45%
Respiratory toxicity - 0.6778 67.78%
Reproductive toxicity + 0.6556 65.56%
Mitochondrial toxicity - 0.5250 52.50%
Nephrotoxicity + 0.6262 62.62%
Acute Oral Toxicity (c) III 0.7284 72.84%
Estrogen receptor binding + 0.5298 52.98%
Androgen receptor binding - 0.5535 55.35%
Thyroid receptor binding - 0.5633 56.33%
Glucocorticoid receptor binding - 0.7829 78.29%
Aromatase binding - 0.7047 70.47%
PPAR gamma - 0.6217 62.17%
Honey bee toxicity - 0.8970 89.70%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.5000 50.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL6007 O75762 Transient receptor potential cation channel subfamily A member 1 59 nM
59 nM
EC50
EC50
PMID: 20356305
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.29% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.59% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.97% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.43% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.05% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.44% 97.09%
CHEMBL1937 Q92769 Histone deacetylase 2 80.24% 94.75%

Cross-Links

Top
PubChem 72503
NPASS NPC4370
ChEMBL CHEMBL254550
LOTUS LTS0105521
wikiData Q3395581